Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 20 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22033020_22033021del |
| Variant | c.15_16del |
| Variant Start Position | 15 |
| Location | Exon 1 |
| Amino Acid Change | p.Gly6Glufs*44 |
| ACMG Call | Pathogenic |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Pathogenic | Effect Type | Frameshift |
| Variant Type | Small deletion |
| PMID | 22577109, 34806794 |
| Article Count | 2 |
| Times Observed | 3-5 |
| Clinical Phenotype | Gait abnormalities, Lower limb deformities, Reduced Serum Phosphate |
| ACMG Categories | pvs1, pm2, ppc |
| ACMG Explanations | pvs1: This is a loss of function variant. pm2: chrX:22051138 ref:AGG alt:A was not found in gnomAD exomes or genomes. chrX:22051137 ref:CAG alt:C was not found in gnomAD exomes or genomes. |
| Variant in Clinvar | Yes |
| ClinVar Classification | Pathogenic |
| Categories In Literature | ppc |
| No Contrary Evidence Found | Yes |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | No |
| Literature Alleles | X-22051138-AGG-A X-22051137-CAG-C |
| GnomAD Alleles | - |
| DBNSFP Alleles | - |
| Other Alleles | - |
| Note | nan |
| Warnings | - |